Global VHH Nanobodies Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
In the peripheral blood of camel species such as alpacas, there is an antibody that naturally lacks light chains. It is a natural dimer formed by two heavy chains, called a heavy chain antibody. The variable region of this heavy chain antibody is called VHH, which can bind to antigens as a single molecule and has high affinity and high specificity. VHH crystals are 2.5nm, 4nm long, and have a molecular weight of only 15 kDa, so they are also called nano antibodies. VHH is not as easy to adhere to each other as artificially modified single-chain antibody fragments (scFV), but is more stable and can even be stored at room temperature. The half-life of nano antibodies can be extended and antibody drugs can be produced by constructing bifunctional domain or trifunctional domain antibodies that recognize HSA, or constructing Fc fusion proteins.
The global VHH Nanobodies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “VHH Nanobodies Industry Forecast” looks at past sales and reviews total world VHH Nanobodies sales in 2023, providing a comprehensive analysis by region and market sector of projected VHH Nanobodies sales for 2024 through 2030. With VHH Nanobodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world VHH Nanobodies industry.
This Insight Report provides a comprehensive analysis of the global VHH Nanobodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on VHH Nanobodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global VHH Nanobodies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for VHH Nanobodies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global VHH Nanobodies.
United States market for VHH Nanobodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for VHH Nanobodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for VHH Nanobodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key VHH Nanobodies players cover Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of VHH Nanobodies market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global VHH Nanobodies market?
What factors are driving VHH Nanobodies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do VHH Nanobodies market opportunities vary by end market size?
How does VHH Nanobodies break out by Type, by Application?
In the peripheral blood of camel species such as alpacas, there is an antibody that naturally lacks light chains. It is a natural dimer formed by two heavy chains, called a heavy chain antibody. The variable region of this heavy chain antibody is called VHH, which can bind to antigens as a single molecule and has high affinity and high specificity. VHH crystals are 2.5nm, 4nm long, and have a molecular weight of only 15 kDa, so they are also called nano antibodies. VHH is not as easy to adhere to each other as artificially modified single-chain antibody fragments (scFV), but is more stable and can even be stored at room temperature. The half-life of nano antibodies can be extended and antibody drugs can be produced by constructing bifunctional domain or trifunctional domain antibodies that recognize HSA, or constructing Fc fusion proteins.
The global VHH Nanobodies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “VHH Nanobodies Industry Forecast” looks at past sales and reviews total world VHH Nanobodies sales in 2023, providing a comprehensive analysis by region and market sector of projected VHH Nanobodies sales for 2024 through 2030. With VHH Nanobodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world VHH Nanobodies industry.
This Insight Report provides a comprehensive analysis of the global VHH Nanobodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on VHH Nanobodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global VHH Nanobodies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for VHH Nanobodies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global VHH Nanobodies.
United States market for VHH Nanobodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for VHH Nanobodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for VHH Nanobodies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key VHH Nanobodies players cover Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of VHH Nanobodies market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monovalent Nanobodies
- Bivalent Nanobodies
- Bispecific Nanobodies
- Multivalent Nanobodies
- Fused Nanobodies
- Treatment
- Diagnosis
- Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sino Biological
- GenScript
- Proteintech Group
- Abiocenter
- MerryBio
- Pregene
- Cusabio
- Biocytogen
- Thermo Fisher Scientific
- QVQuality
- HUABIO
- Jackson ImmunoResearch
What is the 10-year outlook for the global VHH Nanobodies market?
What factors are driving VHH Nanobodies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do VHH Nanobodies market opportunities vary by end market size?
How does VHH Nanobodies break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global VHH Nanobodies Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for VHH Nanobodies by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for VHH Nanobodies by Country/Region, 2019, 2023 & 2030
2.2 VHH Nanobodies Segment by Type
2.2.1 Monovalent Nanobodies
2.2.2 Bivalent Nanobodies
2.2.3 Bispecific Nanobodies
2.2.4 Multivalent Nanobodies
2.2.5 Fused Nanobodies
2.3 VHH Nanobodies Sales by Type
2.3.1 Global VHH Nanobodies Sales Market Share by Type (2019-2024)
2.3.2 Global VHH Nanobodies Revenue and Market Share by Type (2019-2024)
2.3.3 Global VHH Nanobodies Sale Price by Type (2019-2024)
2.4 VHH Nanobodies Segment by Application
2.4.1 Treatment
2.4.2 Diagnosis
2.4.3 Research
2.5 VHH Nanobodies Sales by Application
2.5.1 Global VHH Nanobodies Sale Market Share by Application (2019-2024)
2.5.2 Global VHH Nanobodies Revenue and Market Share by Application (2019-2024)
2.5.3 Global VHH Nanobodies Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global VHH Nanobodies Breakdown Data by Company
3.1.1 Global VHH Nanobodies Annual Sales by Company (2019-2024)
3.1.2 Global VHH Nanobodies Sales Market Share by Company (2019-2024)
3.2 Global VHH Nanobodies Annual Revenue by Company (2019-2024)
3.2.1 Global VHH Nanobodies Revenue by Company (2019-2024)
3.2.2 Global VHH Nanobodies Revenue Market Share by Company (2019-2024)
3.3 Global VHH Nanobodies Sale Price by Company
3.4 Key Manufacturers VHH Nanobodies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers VHH Nanobodies Product Location Distribution
3.4.2 Players VHH Nanobodies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VHH NANOBODIES BY GEOGRAPHIC REGION
4.1 World Historic VHH Nanobodies Market Size by Geographic Region (2019-2024)
4.1.1 Global VHH Nanobodies Annual Sales by Geographic Region (2019-2024)
4.1.2 Global VHH Nanobodies Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic VHH Nanobodies Market Size by Country/Region (2019-2024)
4.2.1 Global VHH Nanobodies Annual Sales by Country/Region (2019-2024)
4.2.2 Global VHH Nanobodies Annual Revenue by Country/Region (2019-2024)
4.3 Americas VHH Nanobodies Sales Growth
4.4 APAC VHH Nanobodies Sales Growth
4.5 Europe VHH Nanobodies Sales Growth
4.6 Middle East & Africa VHH Nanobodies Sales Growth
5 AMERICAS
5.1 Americas VHH Nanobodies Sales by Country
5.1.1 Americas VHH Nanobodies Sales by Country (2019-2024)
5.1.2 Americas VHH Nanobodies Revenue by Country (2019-2024)
5.2 Americas VHH Nanobodies Sales by Type (2019-2024)
5.3 Americas VHH Nanobodies Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC VHH Nanobodies Sales by Region
6.1.1 APAC VHH Nanobodies Sales by Region (2019-2024)
6.1.2 APAC VHH Nanobodies Revenue by Region (2019-2024)
6.2 APAC VHH Nanobodies Sales by Type (2019-2024)
6.3 APAC VHH Nanobodies Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe VHH Nanobodies by Country
7.1.1 Europe VHH Nanobodies Sales by Country (2019-2024)
7.1.2 Europe VHH Nanobodies Revenue by Country (2019-2024)
7.2 Europe VHH Nanobodies Sales by Type (2019-2024)
7.3 Europe VHH Nanobodies Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa VHH Nanobodies by Country
8.1.1 Middle East & Africa VHH Nanobodies Sales by Country (2019-2024)
8.1.2 Middle East & Africa VHH Nanobodies Revenue by Country (2019-2024)
8.2 Middle East & Africa VHH Nanobodies Sales by Type (2019-2024)
8.3 Middle East & Africa VHH Nanobodies Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of VHH Nanobodies
10.3 Manufacturing Process Analysis of VHH Nanobodies
10.4 Industry Chain Structure of VHH Nanobodies
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 VHH Nanobodies Distributors
11.3 VHH Nanobodies Customer
12 WORLD FORECAST REVIEW FOR VHH NANOBODIES BY GEOGRAPHIC REGION
12.1 Global VHH Nanobodies Market Size Forecast by Region
12.1.1 Global VHH Nanobodies Forecast by Region (2025-2030)
12.1.2 Global VHH Nanobodies Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global VHH Nanobodies Forecast by Type (2025-2030)
12.7 Global VHH Nanobodies Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Sino Biological
13.1.1 Sino Biological Company Information
13.1.2 Sino Biological VHH Nanobodies Product Portfolios and Specifications
13.1.3 Sino Biological VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sino Biological Main Business Overview
13.1.5 Sino Biological Latest Developments
13.2 GenScript
13.2.1 GenScript Company Information
13.2.2 GenScript VHH Nanobodies Product Portfolios and Specifications
13.2.3 GenScript VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GenScript Main Business Overview
13.2.5 GenScript Latest Developments
13.3 Proteintech Group
13.3.1 Proteintech Group Company Information
13.3.2 Proteintech Group VHH Nanobodies Product Portfolios and Specifications
13.3.3 Proteintech Group VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Proteintech Group Main Business Overview
13.3.5 Proteintech Group Latest Developments
13.4 Abiocenter
13.4.1 Abiocenter Company Information
13.4.2 Abiocenter VHH Nanobodies Product Portfolios and Specifications
13.4.3 Abiocenter VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abiocenter Main Business Overview
13.4.5 Abiocenter Latest Developments
13.5 MerryBio
13.5.1 MerryBio Company Information
13.5.2 MerryBio VHH Nanobodies Product Portfolios and Specifications
13.5.3 MerryBio VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 MerryBio Main Business Overview
13.5.5 MerryBio Latest Developments
13.6 Pregene
13.6.1 Pregene Company Information
13.6.2 Pregene VHH Nanobodies Product Portfolios and Specifications
13.6.3 Pregene VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Pregene Main Business Overview
13.6.5 Pregene Latest Developments
13.7 Cusabio
13.7.1 Cusabio Company Information
13.7.2 Cusabio VHH Nanobodies Product Portfolios and Specifications
13.7.3 Cusabio VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cusabio Main Business Overview
13.7.5 Cusabio Latest Developments
13.8 Biocytogen
13.8.1 Biocytogen Company Information
13.8.2 Biocytogen VHH Nanobodies Product Portfolios and Specifications
13.8.3 Biocytogen VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Biocytogen Main Business Overview
13.8.5 Biocytogen Latest Developments
13.9 Thermo Fisher Scientific
13.9.1 Thermo Fisher Scientific Company Information
13.9.2 Thermo Fisher Scientific VHH Nanobodies Product Portfolios and Specifications
13.9.3 Thermo Fisher Scientific VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Thermo Fisher Scientific Main Business Overview
13.9.5 Thermo Fisher Scientific Latest Developments
13.10 QVQuality
13.10.1 QVQuality Company Information
13.10.2 QVQuality VHH Nanobodies Product Portfolios and Specifications
13.10.3 QVQuality VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 QVQuality Main Business Overview
13.10.5 QVQuality Latest Developments
13.11 HUABIO
13.11.1 HUABIO Company Information
13.11.2 HUABIO VHH Nanobodies Product Portfolios and Specifications
13.11.3 HUABIO VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 HUABIO Main Business Overview
13.11.5 HUABIO Latest Developments
13.12 Jackson ImmunoResearch
13.12.1 Jackson ImmunoResearch Company Information
13.12.2 Jackson ImmunoResearch VHH Nanobodies Product Portfolios and Specifications
13.12.3 Jackson ImmunoResearch VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Jackson ImmunoResearch Main Business Overview
13.12.5 Jackson ImmunoResearch Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. VHH Nanobodies Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. VHH Nanobodies Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monovalent Nanobodies
Table 4. Major Players of Bivalent Nanobodies
Table 5. Major Players of Bispecific Nanobodies
Table 6. Major Players of Multivalent Nanobodies
Table 7. Major Players ofFused Nanobodies
Table 8. Global VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 9. Global VHH Nanobodies Sales Market Share byType (2019-2024)
Table 10. Global VHH Nanobodies Revenue byType (2019-2024) & ($ million)
Table 11. Global VHH Nanobodies Revenue Market Share byType (2019-2024)
Table 12. Global VHH Nanobodies Sale Price byType (2019-2024) & (K US$/Unit)
Table 13. Global VHH Nanobodies Sale by Application (2019-2024) & (K Units)
Table 14. Global VHH Nanobodies Sale Market Share by Application (2019-2024)
Table 15. Global VHH Nanobodies Revenue by Application (2019-2024) & ($ million)
Table 16. Global VHH Nanobodies Revenue Market Share by Application (2019-2024)
Table 17. Global VHH Nanobodies Sale Price by Application (2019-2024) & (K US$/Unit)
Table 18. Global VHH Nanobodies Sales by Company (2019-2024) & (K Units)
Table 19. Global VHH Nanobodies Sales Market Share by Company (2019-2024)
Table 20. Global VHH Nanobodies Revenue by Company (2019-2024) & ($ millions)
Table 21. Global VHH Nanobodies Revenue Market Share by Company (2019-2024)
Table 22. Global VHH Nanobodies Sale Price by Company (2019-2024) & (K US$/Unit)
Table 23. Key Manufacturers VHH Nanobodies Producing Area Distribution and Sales Area
Table 24. Players VHH Nanobodies Products Offered
Table 25. VHH Nanobodies Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global VHH Nanobodies Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global VHH Nanobodies Sales Market Share Geographic Region (2019-2024)
Table 30. Global VHH Nanobodies Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global VHH Nanobodies Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global VHH Nanobodies Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global VHH Nanobodies Sales Market Share by Country/Region (2019-2024)
Table 34. Global VHH Nanobodies Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global VHH Nanobodies Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas VHH Nanobodies Sales by Country (2019-2024) & (K Units)
Table 37. Americas VHH Nanobodies Sales Market Share by Country (2019-2024)
Table 38. Americas VHH Nanobodies Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 40. Americas VHH Nanobodies Sales by Application (2019-2024) & (K Units)
Table 41. APAC VHH Nanobodies Sales by Region (2019-2024) & (K Units)
Table 42. APAC VHH Nanobodies Sales Market Share by Region (2019-2024)
Table 43. APAC VHH Nanobodies Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 45. APAC VHH Nanobodies Sales by Application (2019-2024) & (K Units)
Table 46. Europe VHH Nanobodies Sales by Country (2019-2024) & (K Units)
Table 47. Europe VHH Nanobodies Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 49. Europe VHH Nanobodies Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa VHH Nanobodies Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa VHH Nanobodies Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 53. Middle East & Africa VHH Nanobodies Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of VHH Nanobodies
Table 55. Key Market Challenges & Risks of VHH Nanobodies
Table 56. Key IndustryTrends of VHH Nanobodies
Table 57. VHH Nanobodies Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. VHH Nanobodies Distributors List
Table 60. VHH Nanobodies Customer List
Table 61. Global VHH Nanobodies SalesForecast by Region (2025-2030) & (K Units)
Table 62. Global VHH Nanobodies RevenueForecast by Region (2025-2030) & ($ millions)
Table 63. Americas VHH Nanobodies SalesForecast by Country (2025-2030) & (K Units)
Table 64. Americas VHH Nanobodies Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 65. APAC VHH Nanobodies SalesForecast by Region (2025-2030) & (K Units)
Table 66. APAC VHH Nanobodies Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Europe VHH Nanobodies SalesForecast by Country (2025-2030) & (K Units)
Table 68. Europe VHH Nanobodies RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa VHH Nanobodies SalesForecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa VHH Nanobodies RevenueForecast by Country (2025-2030) & ($ millions)
Table 71. Global VHH Nanobodies SalesForecast byType (2025-2030) & (K Units)
Table 72. Global VHH Nanobodies RevenueForecast byType (2025-2030) & ($ millions)
Table 73. Global VHH Nanobodies SalesForecast by Application (2025-2030) & (K Units)
Table 74. Global VHH Nanobodies RevenueForecast by Application (2025-2030) & ($ millions)
Table 75. Sino Biological Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 76. Sino Biological VHH Nanobodies Product Portfolios and Specifications
Table 77. Sino Biological VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 78. Sino Biological Main Business
Table 79. Sino Biological Latest Developments
Table 80. GenScript Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 81. GenScript VHH Nanobodies Product Portfolios and Specifications
Table 82. GenScript VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 83. GenScript Main Business
Table 84. GenScript Latest Developments
Table 85. Proteintech Group Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 86. Proteintech Group VHH Nanobodies Product Portfolios and Specifications
Table 87. Proteintech Group VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 88. Proteintech Group Main Business
Table 89. Proteintech Group Latest Developments
Table 90. Abiocenter Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 91. Abiocenter VHH Nanobodies Product Portfolios and Specifications
Table 92. Abiocenter VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 93. Abiocenter Main Business
Table 94. Abiocenter Latest Developments
Table 95. MerryBio Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 96. MerryBio VHH Nanobodies Product Portfolios and Specifications
Table 97. MerryBio VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 98. MerryBio Main Business
Table 99. MerryBio Latest Developments
Table 100. Pregene Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 101. Pregene VHH Nanobodies Product Portfolios and Specifications
Table 102. Pregene VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 103. Pregene Main Business
Table 104. Pregene Latest Developments
Table 105. Cusabio Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 106. Cusabio VHH Nanobodies Product Portfolios and Specifications
Table 107. Cusabio VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 108. Cusabio Main Business
Table 109. Cusabio Latest Developments
Table 110. Biocytogen Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 111. Biocytogen VHH Nanobodies Product Portfolios and Specifications
Table 112. Biocytogen VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 113. Biocytogen Main Business
Table 114. Biocytogen Latest Developments
Table 115.ThermoFisher Scientific Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 116.ThermoFisher Scientific VHH Nanobodies Product Portfolios and Specifications
Table 117.ThermoFisher Scientific VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 118.ThermoFisher Scientific Main Business
Table 119.ThermoFisher Scientific Latest Developments
Table 120. QVQuality Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 121. QVQuality VHH Nanobodies Product Portfolios and Specifications
Table 122. QVQuality VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 123. QVQuality Main Business
Table 124. QVQuality Latest Developments
Table 125. HUABIO Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 126. HUABIO VHH Nanobodies Product Portfolios and Specifications
Table 127. HUABIO VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 128. HUABIO Main Business
Table 129. HUABIO Latest Developments
Table 130. Jackson ImmunoResearch Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 131. Jackson ImmunoResearch VHH Nanobodies Product Portfolios and Specifications
Table 132. Jackson ImmunoResearch VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 133. Jackson ImmunoResearch Main Business
Table 134. Jackson ImmunoResearch Latest Developments
LIST OFFIGURES
Figure 1. Picture of VHH Nanobodies
Figure 2. VHH Nanobodies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global VHH Nanobodies Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global VHH Nanobodies Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. VHH Nanobodies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. VHH Nanobodies Sales Market Share by Country/Region (2023)
Figure 10. VHH Nanobodies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monovalent Nanobodies
Figure 12. Product Picture of Bivalent Nanobodies
Figure 13. Product Picture of Bispecific Nanobodies
Figure 14. Product Picture of Multivalent Nanobodies
Figure 15. Product Picture ofFused Nanobodies
Figure 16. Global VHH Nanobodies Sales Market Share byType in 2023
Figure 17. Global VHH Nanobodies Revenue Market Share byType (2019-2024)
Figure 18. VHH Nanobodies Consumed inTreatment
Figure 19. Global VHH Nanobodies Market:Treatment (2019-2024) & (K Units)
Figure 20. VHH Nanobodies Consumed in Diagnosis
Figure 21. Global VHH Nanobodies Market: Diagnosis (2019-2024) & (K Units)
Figure 22. VHH Nanobodies Consumed in Research
Figure 23. Global VHH Nanobodies Market: Research (2019-2024) & (K Units)
Figure 24. Global VHH Nanobodies Sale Market Share by Application (2023)
Figure 25. Global VHH Nanobodies Revenue Market Share by Application in 2023
Figure 26. VHH Nanobodies Sales by Company in 2023 (K Units)
Figure 27. Global VHH Nanobodies Sales Market Share by Company in 2023
Figure 28. VHH Nanobodies Revenue by Company in 2023 ($ millions)
Figure 29. Global VHH Nanobodies Revenue Market Share by Company in 2023
Figure 30. Global VHH Nanobodies Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global VHH Nanobodies Revenue Market Share by Geographic Region in 2023
Figure 32. Americas VHH Nanobodies Sales 2019-2024 (K Units)
Figure 33. Americas VHH Nanobodies Revenue 2019-2024 ($ millions)
Figure 34. APAC VHH Nanobodies Sales 2019-2024 (K Units)
Figure 35. APAC VHH Nanobodies Revenue 2019-2024 ($ millions)
Figure 36. Europe VHH Nanobodies Sales 2019-2024 (K Units)
Figure 37. Europe VHH Nanobodies Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa VHH Nanobodies Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa VHH Nanobodies Revenue 2019-2024 ($ millions)
Figure 40. Americas VHH Nanobodies Sales Market Share by Country in 2023
Figure 41. Americas VHH Nanobodies Revenue Market Share by Country (2019-2024)
Figure 42. Americas VHH Nanobodies Sales Market Share byType (2019-2024)
Figure 43. Americas VHH Nanobodies Sales Market Share by Application (2019-2024)
Figure 44. United States VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC VHH Nanobodies Sales Market Share by Region in 2023
Figure 49. APAC VHH Nanobodies Revenue Market Share by Region (2019-2024)
Figure 50. APAC VHH Nanobodies Sales Market Share byType (2019-2024)
Figure 51. APAC VHH Nanobodies Sales Market Share by Application (2019-2024)
Figure 52. China VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 56. India VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 58. ChinaTaiwan VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe VHH Nanobodies Sales Market Share by Country in 2023
Figure 60. Europe VHH Nanobodies Revenue Market Share by Country (2019-2024)
Figure 61. Europe VHH Nanobodies Sales Market Share byType (2019-2024)
Figure 62. Europe VHH Nanobodies Sales Market Share by Application (2019-2024)
Figure 63. Germany VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 64.France VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 65. UK VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa VHH Nanobodies Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa VHH Nanobodies Sales Market Share byType (2019-2024)
Figure 70. Middle East & Africa VHH Nanobodies Sales Market Share by Application (2019-2024)
Figure 71. Egypt VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 74.Turkey VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of VHH Nanobodies in 2023
Figure 77. Manufacturing Process Analysis of VHH Nanobodies
Figure 78. Industry Chain Structure of VHH Nanobodies
Figure 79. Channels of Distribution
Figure 80. Global VHH Nanobodies Sales MarketForecast by Region (2025-2030)
Figure 81. Global VHH Nanobodies Revenue Market ShareForecast by Region (2025-2030)
Figure 82. Global VHH Nanobodies Sales Market ShareForecast byType (2025-2030)
Figure 83. Global VHH Nanobodies Revenue Market ShareForecast byType (2025-2030)
Figure 84. Global VHH Nanobodies Sales Market ShareForecast by Application (2025-2030)
Figure 85. Global VHH Nanobodies Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global VHH Nanobodies Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for VHH Nanobodies by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for VHH Nanobodies by Country/Region, 2019, 2023 & 2030
2.2 VHH Nanobodies Segment by Type
2.2.1 Monovalent Nanobodies
2.2.2 Bivalent Nanobodies
2.2.3 Bispecific Nanobodies
2.2.4 Multivalent Nanobodies
2.2.5 Fused Nanobodies
2.3 VHH Nanobodies Sales by Type
2.3.1 Global VHH Nanobodies Sales Market Share by Type (2019-2024)
2.3.2 Global VHH Nanobodies Revenue and Market Share by Type (2019-2024)
2.3.3 Global VHH Nanobodies Sale Price by Type (2019-2024)
2.4 VHH Nanobodies Segment by Application
2.4.1 Treatment
2.4.2 Diagnosis
2.4.3 Research
2.5 VHH Nanobodies Sales by Application
2.5.1 Global VHH Nanobodies Sale Market Share by Application (2019-2024)
2.5.2 Global VHH Nanobodies Revenue and Market Share by Application (2019-2024)
2.5.3 Global VHH Nanobodies Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global VHH Nanobodies Breakdown Data by Company
3.1.1 Global VHH Nanobodies Annual Sales by Company (2019-2024)
3.1.2 Global VHH Nanobodies Sales Market Share by Company (2019-2024)
3.2 Global VHH Nanobodies Annual Revenue by Company (2019-2024)
3.2.1 Global VHH Nanobodies Revenue by Company (2019-2024)
3.2.2 Global VHH Nanobodies Revenue Market Share by Company (2019-2024)
3.3 Global VHH Nanobodies Sale Price by Company
3.4 Key Manufacturers VHH Nanobodies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers VHH Nanobodies Product Location Distribution
3.4.2 Players VHH Nanobodies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VHH NANOBODIES BY GEOGRAPHIC REGION
4.1 World Historic VHH Nanobodies Market Size by Geographic Region (2019-2024)
4.1.1 Global VHH Nanobodies Annual Sales by Geographic Region (2019-2024)
4.1.2 Global VHH Nanobodies Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic VHH Nanobodies Market Size by Country/Region (2019-2024)
4.2.1 Global VHH Nanobodies Annual Sales by Country/Region (2019-2024)
4.2.2 Global VHH Nanobodies Annual Revenue by Country/Region (2019-2024)
4.3 Americas VHH Nanobodies Sales Growth
4.4 APAC VHH Nanobodies Sales Growth
4.5 Europe VHH Nanobodies Sales Growth
4.6 Middle East & Africa VHH Nanobodies Sales Growth
5 AMERICAS
5.1 Americas VHH Nanobodies Sales by Country
5.1.1 Americas VHH Nanobodies Sales by Country (2019-2024)
5.1.2 Americas VHH Nanobodies Revenue by Country (2019-2024)
5.2 Americas VHH Nanobodies Sales by Type (2019-2024)
5.3 Americas VHH Nanobodies Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC VHH Nanobodies Sales by Region
6.1.1 APAC VHH Nanobodies Sales by Region (2019-2024)
6.1.2 APAC VHH Nanobodies Revenue by Region (2019-2024)
6.2 APAC VHH Nanobodies Sales by Type (2019-2024)
6.3 APAC VHH Nanobodies Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe VHH Nanobodies by Country
7.1.1 Europe VHH Nanobodies Sales by Country (2019-2024)
7.1.2 Europe VHH Nanobodies Revenue by Country (2019-2024)
7.2 Europe VHH Nanobodies Sales by Type (2019-2024)
7.3 Europe VHH Nanobodies Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa VHH Nanobodies by Country
8.1.1 Middle East & Africa VHH Nanobodies Sales by Country (2019-2024)
8.1.2 Middle East & Africa VHH Nanobodies Revenue by Country (2019-2024)
8.2 Middle East & Africa VHH Nanobodies Sales by Type (2019-2024)
8.3 Middle East & Africa VHH Nanobodies Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of VHH Nanobodies
10.3 Manufacturing Process Analysis of VHH Nanobodies
10.4 Industry Chain Structure of VHH Nanobodies
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 VHH Nanobodies Distributors
11.3 VHH Nanobodies Customer
12 WORLD FORECAST REVIEW FOR VHH NANOBODIES BY GEOGRAPHIC REGION
12.1 Global VHH Nanobodies Market Size Forecast by Region
12.1.1 Global VHH Nanobodies Forecast by Region (2025-2030)
12.1.2 Global VHH Nanobodies Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global VHH Nanobodies Forecast by Type (2025-2030)
12.7 Global VHH Nanobodies Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Sino Biological
13.1.1 Sino Biological Company Information
13.1.2 Sino Biological VHH Nanobodies Product Portfolios and Specifications
13.1.3 Sino Biological VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sino Biological Main Business Overview
13.1.5 Sino Biological Latest Developments
13.2 GenScript
13.2.1 GenScript Company Information
13.2.2 GenScript VHH Nanobodies Product Portfolios and Specifications
13.2.3 GenScript VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GenScript Main Business Overview
13.2.5 GenScript Latest Developments
13.3 Proteintech Group
13.3.1 Proteintech Group Company Information
13.3.2 Proteintech Group VHH Nanobodies Product Portfolios and Specifications
13.3.3 Proteintech Group VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Proteintech Group Main Business Overview
13.3.5 Proteintech Group Latest Developments
13.4 Abiocenter
13.4.1 Abiocenter Company Information
13.4.2 Abiocenter VHH Nanobodies Product Portfolios and Specifications
13.4.3 Abiocenter VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abiocenter Main Business Overview
13.4.5 Abiocenter Latest Developments
13.5 MerryBio
13.5.1 MerryBio Company Information
13.5.2 MerryBio VHH Nanobodies Product Portfolios and Specifications
13.5.3 MerryBio VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 MerryBio Main Business Overview
13.5.5 MerryBio Latest Developments
13.6 Pregene
13.6.1 Pregene Company Information
13.6.2 Pregene VHH Nanobodies Product Portfolios and Specifications
13.6.3 Pregene VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Pregene Main Business Overview
13.6.5 Pregene Latest Developments
13.7 Cusabio
13.7.1 Cusabio Company Information
13.7.2 Cusabio VHH Nanobodies Product Portfolios and Specifications
13.7.3 Cusabio VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cusabio Main Business Overview
13.7.5 Cusabio Latest Developments
13.8 Biocytogen
13.8.1 Biocytogen Company Information
13.8.2 Biocytogen VHH Nanobodies Product Portfolios and Specifications
13.8.3 Biocytogen VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Biocytogen Main Business Overview
13.8.5 Biocytogen Latest Developments
13.9 Thermo Fisher Scientific
13.9.1 Thermo Fisher Scientific Company Information
13.9.2 Thermo Fisher Scientific VHH Nanobodies Product Portfolios and Specifications
13.9.3 Thermo Fisher Scientific VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Thermo Fisher Scientific Main Business Overview
13.9.5 Thermo Fisher Scientific Latest Developments
13.10 QVQuality
13.10.1 QVQuality Company Information
13.10.2 QVQuality VHH Nanobodies Product Portfolios and Specifications
13.10.3 QVQuality VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 QVQuality Main Business Overview
13.10.5 QVQuality Latest Developments
13.11 HUABIO
13.11.1 HUABIO Company Information
13.11.2 HUABIO VHH Nanobodies Product Portfolios and Specifications
13.11.3 HUABIO VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 HUABIO Main Business Overview
13.11.5 HUABIO Latest Developments
13.12 Jackson ImmunoResearch
13.12.1 Jackson ImmunoResearch Company Information
13.12.2 Jackson ImmunoResearch VHH Nanobodies Product Portfolios and Specifications
13.12.3 Jackson ImmunoResearch VHH Nanobodies Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Jackson ImmunoResearch Main Business Overview
13.12.5 Jackson ImmunoResearch Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. VHH Nanobodies Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. VHH Nanobodies Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monovalent Nanobodies
Table 4. Major Players of Bivalent Nanobodies
Table 5. Major Players of Bispecific Nanobodies
Table 6. Major Players of Multivalent Nanobodies
Table 7. Major Players ofFused Nanobodies
Table 8. Global VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 9. Global VHH Nanobodies Sales Market Share byType (2019-2024)
Table 10. Global VHH Nanobodies Revenue byType (2019-2024) & ($ million)
Table 11. Global VHH Nanobodies Revenue Market Share byType (2019-2024)
Table 12. Global VHH Nanobodies Sale Price byType (2019-2024) & (K US$/Unit)
Table 13. Global VHH Nanobodies Sale by Application (2019-2024) & (K Units)
Table 14. Global VHH Nanobodies Sale Market Share by Application (2019-2024)
Table 15. Global VHH Nanobodies Revenue by Application (2019-2024) & ($ million)
Table 16. Global VHH Nanobodies Revenue Market Share by Application (2019-2024)
Table 17. Global VHH Nanobodies Sale Price by Application (2019-2024) & (K US$/Unit)
Table 18. Global VHH Nanobodies Sales by Company (2019-2024) & (K Units)
Table 19. Global VHH Nanobodies Sales Market Share by Company (2019-2024)
Table 20. Global VHH Nanobodies Revenue by Company (2019-2024) & ($ millions)
Table 21. Global VHH Nanobodies Revenue Market Share by Company (2019-2024)
Table 22. Global VHH Nanobodies Sale Price by Company (2019-2024) & (K US$/Unit)
Table 23. Key Manufacturers VHH Nanobodies Producing Area Distribution and Sales Area
Table 24. Players VHH Nanobodies Products Offered
Table 25. VHH Nanobodies Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global VHH Nanobodies Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global VHH Nanobodies Sales Market Share Geographic Region (2019-2024)
Table 30. Global VHH Nanobodies Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global VHH Nanobodies Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global VHH Nanobodies Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global VHH Nanobodies Sales Market Share by Country/Region (2019-2024)
Table 34. Global VHH Nanobodies Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global VHH Nanobodies Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas VHH Nanobodies Sales by Country (2019-2024) & (K Units)
Table 37. Americas VHH Nanobodies Sales Market Share by Country (2019-2024)
Table 38. Americas VHH Nanobodies Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 40. Americas VHH Nanobodies Sales by Application (2019-2024) & (K Units)
Table 41. APAC VHH Nanobodies Sales by Region (2019-2024) & (K Units)
Table 42. APAC VHH Nanobodies Sales Market Share by Region (2019-2024)
Table 43. APAC VHH Nanobodies Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 45. APAC VHH Nanobodies Sales by Application (2019-2024) & (K Units)
Table 46. Europe VHH Nanobodies Sales by Country (2019-2024) & (K Units)
Table 47. Europe VHH Nanobodies Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 49. Europe VHH Nanobodies Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa VHH Nanobodies Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa VHH Nanobodies Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa VHH Nanobodies Sales byType (2019-2024) & (K Units)
Table 53. Middle East & Africa VHH Nanobodies Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of VHH Nanobodies
Table 55. Key Market Challenges & Risks of VHH Nanobodies
Table 56. Key IndustryTrends of VHH Nanobodies
Table 57. VHH Nanobodies Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. VHH Nanobodies Distributors List
Table 60. VHH Nanobodies Customer List
Table 61. Global VHH Nanobodies SalesForecast by Region (2025-2030) & (K Units)
Table 62. Global VHH Nanobodies RevenueForecast by Region (2025-2030) & ($ millions)
Table 63. Americas VHH Nanobodies SalesForecast by Country (2025-2030) & (K Units)
Table 64. Americas VHH Nanobodies Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 65. APAC VHH Nanobodies SalesForecast by Region (2025-2030) & (K Units)
Table 66. APAC VHH Nanobodies Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Europe VHH Nanobodies SalesForecast by Country (2025-2030) & (K Units)
Table 68. Europe VHH Nanobodies RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa VHH Nanobodies SalesForecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa VHH Nanobodies RevenueForecast by Country (2025-2030) & ($ millions)
Table 71. Global VHH Nanobodies SalesForecast byType (2025-2030) & (K Units)
Table 72. Global VHH Nanobodies RevenueForecast byType (2025-2030) & ($ millions)
Table 73. Global VHH Nanobodies SalesForecast by Application (2025-2030) & (K Units)
Table 74. Global VHH Nanobodies RevenueForecast by Application (2025-2030) & ($ millions)
Table 75. Sino Biological Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 76. Sino Biological VHH Nanobodies Product Portfolios and Specifications
Table 77. Sino Biological VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 78. Sino Biological Main Business
Table 79. Sino Biological Latest Developments
Table 80. GenScript Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 81. GenScript VHH Nanobodies Product Portfolios and Specifications
Table 82. GenScript VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 83. GenScript Main Business
Table 84. GenScript Latest Developments
Table 85. Proteintech Group Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 86. Proteintech Group VHH Nanobodies Product Portfolios and Specifications
Table 87. Proteintech Group VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 88. Proteintech Group Main Business
Table 89. Proteintech Group Latest Developments
Table 90. Abiocenter Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 91. Abiocenter VHH Nanobodies Product Portfolios and Specifications
Table 92. Abiocenter VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 93. Abiocenter Main Business
Table 94. Abiocenter Latest Developments
Table 95. MerryBio Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 96. MerryBio VHH Nanobodies Product Portfolios and Specifications
Table 97. MerryBio VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 98. MerryBio Main Business
Table 99. MerryBio Latest Developments
Table 100. Pregene Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 101. Pregene VHH Nanobodies Product Portfolios and Specifications
Table 102. Pregene VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 103. Pregene Main Business
Table 104. Pregene Latest Developments
Table 105. Cusabio Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 106. Cusabio VHH Nanobodies Product Portfolios and Specifications
Table 107. Cusabio VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 108. Cusabio Main Business
Table 109. Cusabio Latest Developments
Table 110. Biocytogen Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 111. Biocytogen VHH Nanobodies Product Portfolios and Specifications
Table 112. Biocytogen VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 113. Biocytogen Main Business
Table 114. Biocytogen Latest Developments
Table 115.ThermoFisher Scientific Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 116.ThermoFisher Scientific VHH Nanobodies Product Portfolios and Specifications
Table 117.ThermoFisher Scientific VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 118.ThermoFisher Scientific Main Business
Table 119.ThermoFisher Scientific Latest Developments
Table 120. QVQuality Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 121. QVQuality VHH Nanobodies Product Portfolios and Specifications
Table 122. QVQuality VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 123. QVQuality Main Business
Table 124. QVQuality Latest Developments
Table 125. HUABIO Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 126. HUABIO VHH Nanobodies Product Portfolios and Specifications
Table 127. HUABIO VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 128. HUABIO Main Business
Table 129. HUABIO Latest Developments
Table 130. Jackson ImmunoResearch Basic Information, VHH Nanobodies Manufacturing Base, Sales Area and Its Competitors
Table 131. Jackson ImmunoResearch VHH Nanobodies Product Portfolios and Specifications
Table 132. Jackson ImmunoResearch VHH Nanobodies Sales (K Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 133. Jackson ImmunoResearch Main Business
Table 134. Jackson ImmunoResearch Latest Developments
LIST OFFIGURES
Figure 1. Picture of VHH Nanobodies
Figure 2. VHH Nanobodies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global VHH Nanobodies Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global VHH Nanobodies Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. VHH Nanobodies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. VHH Nanobodies Sales Market Share by Country/Region (2023)
Figure 10. VHH Nanobodies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monovalent Nanobodies
Figure 12. Product Picture of Bivalent Nanobodies
Figure 13. Product Picture of Bispecific Nanobodies
Figure 14. Product Picture of Multivalent Nanobodies
Figure 15. Product Picture ofFused Nanobodies
Figure 16. Global VHH Nanobodies Sales Market Share byType in 2023
Figure 17. Global VHH Nanobodies Revenue Market Share byType (2019-2024)
Figure 18. VHH Nanobodies Consumed inTreatment
Figure 19. Global VHH Nanobodies Market:Treatment (2019-2024) & (K Units)
Figure 20. VHH Nanobodies Consumed in Diagnosis
Figure 21. Global VHH Nanobodies Market: Diagnosis (2019-2024) & (K Units)
Figure 22. VHH Nanobodies Consumed in Research
Figure 23. Global VHH Nanobodies Market: Research (2019-2024) & (K Units)
Figure 24. Global VHH Nanobodies Sale Market Share by Application (2023)
Figure 25. Global VHH Nanobodies Revenue Market Share by Application in 2023
Figure 26. VHH Nanobodies Sales by Company in 2023 (K Units)
Figure 27. Global VHH Nanobodies Sales Market Share by Company in 2023
Figure 28. VHH Nanobodies Revenue by Company in 2023 ($ millions)
Figure 29. Global VHH Nanobodies Revenue Market Share by Company in 2023
Figure 30. Global VHH Nanobodies Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global VHH Nanobodies Revenue Market Share by Geographic Region in 2023
Figure 32. Americas VHH Nanobodies Sales 2019-2024 (K Units)
Figure 33. Americas VHH Nanobodies Revenue 2019-2024 ($ millions)
Figure 34. APAC VHH Nanobodies Sales 2019-2024 (K Units)
Figure 35. APAC VHH Nanobodies Revenue 2019-2024 ($ millions)
Figure 36. Europe VHH Nanobodies Sales 2019-2024 (K Units)
Figure 37. Europe VHH Nanobodies Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa VHH Nanobodies Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa VHH Nanobodies Revenue 2019-2024 ($ millions)
Figure 40. Americas VHH Nanobodies Sales Market Share by Country in 2023
Figure 41. Americas VHH Nanobodies Revenue Market Share by Country (2019-2024)
Figure 42. Americas VHH Nanobodies Sales Market Share byType (2019-2024)
Figure 43. Americas VHH Nanobodies Sales Market Share by Application (2019-2024)
Figure 44. United States VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC VHH Nanobodies Sales Market Share by Region in 2023
Figure 49. APAC VHH Nanobodies Revenue Market Share by Region (2019-2024)
Figure 50. APAC VHH Nanobodies Sales Market Share byType (2019-2024)
Figure 51. APAC VHH Nanobodies Sales Market Share by Application (2019-2024)
Figure 52. China VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 56. India VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 58. ChinaTaiwan VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe VHH Nanobodies Sales Market Share by Country in 2023
Figure 60. Europe VHH Nanobodies Revenue Market Share by Country (2019-2024)
Figure 61. Europe VHH Nanobodies Sales Market Share byType (2019-2024)
Figure 62. Europe VHH Nanobodies Sales Market Share by Application (2019-2024)
Figure 63. Germany VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 64.France VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 65. UK VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa VHH Nanobodies Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa VHH Nanobodies Sales Market Share byType (2019-2024)
Figure 70. Middle East & Africa VHH Nanobodies Sales Market Share by Application (2019-2024)
Figure 71. Egypt VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 74.Turkey VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries VHH Nanobodies Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of VHH Nanobodies in 2023
Figure 77. Manufacturing Process Analysis of VHH Nanobodies
Figure 78. Industry Chain Structure of VHH Nanobodies
Figure 79. Channels of Distribution
Figure 80. Global VHH Nanobodies Sales MarketForecast by Region (2025-2030)
Figure 81. Global VHH Nanobodies Revenue Market ShareForecast by Region (2025-2030)
Figure 82. Global VHH Nanobodies Sales Market ShareForecast byType (2025-2030)
Figure 83. Global VHH Nanobodies Revenue Market ShareForecast byType (2025-2030)
Figure 84. Global VHH Nanobodies Sales Market ShareForecast by Application (2025-2030)
Figure 85. Global VHH Nanobodies Revenue Market ShareForecast by Application (2025-2030)
